62 related articles for article (PubMed ID: 24601847)
1. A novel and a previously described compound heterozygous PKLR gene mutations causing pyruvate kinase deficiency in a Chinese child.
Li H; Gu P; Yao RE; Wang J; Fu Q; Wang J
Fetal Pediatr Pathol; 2014 Jun; 33(3):182-90. PubMed ID: 24601847
[TBL] [Abstract][Full Text] [Related]
2. Neonatal Thrombocytopenia as a Presenting Finding in de novo Pyruvate Kinase Deficiency.
Dulmovits BM; Wild KT; Flibotte J; Lambert MP; Kwiatkowski J; Thom CS
Neonatology; 2023; 120(5):661-665. PubMed ID: 37473739
[TBL] [Abstract][Full Text] [Related]
3. Updates and advances in pyruvate kinase deficiency.
Luke N; Hillier K; Al-Samkari H; Grace RF
Trends Mol Med; 2023 May; 29(5):406-418. PubMed ID: 36935283
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcome and genotype analysis of four Chinese children with pyruvate kinase deficiency.
Xie F; Gan L; Lei L; Cai T; Gao Y; Liu X; Cai B; Zhou L
Mol Genet Genomic Med; 2023 Nov; 11(11):e2239. PubMed ID: 37466302
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of pyruvate kinase deficiency: A systematic literature review.
Secrest MH; Storm M; Carrington C; Casso D; Gilroy K; Pladson L; Boscoe AN
Eur J Haematol; 2020 Aug; 105(2):173-184. PubMed ID: 32279356
[TBL] [Abstract][Full Text] [Related]
6. Anemia in the Neonate: The Differential Diagnosis and Treatment.
Nassin ML; Lapping-Carr G; de Jong JL
Pediatr Ann; 2015 Jul; 44(7):e159-63. PubMed ID: 26171704
[TBL] [Abstract][Full Text] [Related]
7. Consensus document for the diagnosis and treatment of pyruvate kinase deficiency.
Morado M; Villegas AM; de la Iglesia S; Martínez-Nieto J; Del Orbe Barreto R; Beneitez D; Salido E;
Med Clin (Barc); 2021 Sep; 157(5):253.e1-253.e8. PubMed ID: 33431182
[TBL] [Abstract][Full Text] [Related]
8. Novel
Fawaz N; Beshlawi I; Alqasim A; Zachariah M; Russo R; Andolfo I; Gambale A; Pathare A; Iolascon A
Clin Case Rep; 2022 Feb; 10(2):e05315. PubMed ID: 35154711
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in the use of pyruvate kinase activators as a new approach for treating sickle cell disease.
Parekh DS; Eaton WA; Thein SL
Blood; 2024 Mar; 143(10):866-871. PubMed ID: 38118071
[TBL] [Abstract][Full Text] [Related]
10. Erythrocytic pyruvate kinase mutations causing hemolytic anemia, osteosclerosis, and secondary hemochromatosis in dogs.
Gultekin GI; Raj K; Foureman P; Lehman S; Manhart K; Abdulmalik O; Giger U
J Vet Intern Med; 2012; 26(4):935-44. PubMed ID: 22805166
[TBL] [Abstract][Full Text] [Related]
11. Mitapivat: A Review in Pyruvate Kinase Deficiency in Adults.
Zhuang-Yan A; Shirley M
Drugs; 2023 Nov; 83(17):1613-1620. PubMed ID: 37991635
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate kinase activators for treatment of pyruvate kinase deficiency.
Grace RF
Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):97-106. PubMed ID: 38066940
[TBL] [Abstract][Full Text] [Related]
13. Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency.
Zagadailov E; Al-Samkari H; Boscoe AN; McGee B; Shi S; Macaulay D; Shi L; Garcia-Horton V
Hematology; 2024 Dec; 29(1):2290746. PubMed ID: 38095306
[TBL] [Abstract][Full Text] [Related]
14. Acquired pseudoxanthoma elasticum-like syndrome and pyruvate kinase deficiency: a case of iron overload?
Robert M; Audebert S; Eveillard JR; Galacteros F; El Aridi L; Glen LF; Billon C; Misery L; Abasq-Thomas C
Eur J Dermatol; 2023 Jun; 33(3):319-320. PubMed ID: 37594352
[No Abstract] [Full Text] [Related]
15. Pyruvate kinase deficiency in 29 Turkish patients with two novel intronic variants.
Gök V; Leblebisatan G; Gürlek Gökçebay D; Güler S; Doğan ME; Tuğ Bozdoğan S; Koca Yozgat A; Özcan A; Pekpak Şahinoğlu E; Tokgöz H; Çil M; Özemri Sağ Ş; Yilmaz E; Şaşmaz Hİ; Evim MS; Akbayram S; Karadoğan M; Mutlu FT; Boğa İ; Yeter Doğan B; Yarali N; Çalişkan Ü; Bişgin A; Temel ŞG; Proven M; Gibson K; Demir BŞ; Saraçoğlu H; Eken A; Karakükçü Ç; Karakükçü M; Güneş AM; Özbek NY; Kilinç Y; Patiroğlu T; Özdemir MA; Roy NBA; Ünal E
Br J Haematol; 2024 May; ():. PubMed ID: 38811201
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Demographic Characteristics of Pyruvate Kinase Deficiency Patients: A Comprehensive Case Series Analysis.
Nasiri A; Haroon A; Alzahrani H
Cureus; 2024 May; 16(5):e60035. PubMed ID: 38736761
[TBL] [Abstract][Full Text] [Related]
17. A previously unknown mutation in the pyruvate kinase gene (PKLR) identified from a neonate with severe jaundice.
Yaish HM; Nussenzveig RH; Agarwal AM; Siddiqui AH; Christensen RD
Neonatology; 2014; 106(2):140-2. PubMed ID: 24969675
[TBL] [Abstract][Full Text] [Related]
18. Erythrocyte pyruvate kinase deficiency: 2015 status report.
Grace RF; Zanella A; Neufeld EJ; Morton DH; Eber S; Yaish H; Glader B
Am J Hematol; 2015 Sep; 90(9):825-30. PubMed ID: 26087744
[TBL] [Abstract][Full Text] [Related]
19. Management of pyruvate kinase deficiency in children and adults.
Grace RF; Barcellini W
Blood; 2020 Sep; 136(11):1241-1249. PubMed ID: 32702739
[TBL] [Abstract][Full Text] [Related]
20. PYK-SubstitutionOME: an integrated database containing allosteric coupling, ligand affinity and mutational, structural, pathological, bioinformatic and computational information about pyruvate kinase isozymes.
Swint-Kruse L; Dougherty LL; Page B; Wu T; O'Neil PT; Prasannan CB; Timmons C; Tang Q; Parente DJ; Sreenivasan S; Holyoak T; Fenton AW
Database (Oxford); 2023 May; 2023():. PubMed ID: 37171062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
